Sign in
|
Join
|
Help
in
Current Tags
(Entire Site)
Home
Blogs
Directory
Feeds
All Posts (RSS)
All Posts (OPML)
Filters
All Posts
Internal Posts
External Posts
Photos
Directory
Feeds
All Posts (RSS)
Forums
Directory
Feeds
All Posts (RSS)
Filters
Active Threads
Forum Subscriptions
My Forums
Posts Containing Video
Unanswered Posts
Unread Posts
Downloads
Tags
Users
Control Panel
Blogs
Write a new post...
Photos
Post a new photo...
arachnode.net
»
All Tags
»
Prices (Fares, Fees and Rates)
»
Drugs (Pharmaceuticals)
(
RSS
)
Browse by Tags
Amgen Inc|AMGN|NASDAQ
Anemia
Cancer
Decisions and Verdicts
Hypertension
Johnson & Johnson Inc
Malaria
Medicine and Health
Pfizer Inc|PFE|NYSE
Rebates
Suits and Litigation
The Evidence Gap: The Minimal Impact of a Big Hypertension Study
Critics say drug firms worked to discredit a clinical trial that found that inexpensive pills for hypertension worked better than newer drugs.
Posted to
partners.userland.com
(Weblog)
by
Anonymous
on 11-27-2008
The Evidence Gap: The Minimal Impact of a Big Hypertension Study
Critics say drug firms worked to discredit a clinical trial that found that inexpensive pills for hypertension worked better than newer drugs.
Posted to
nytimes.com
(Weblog)
by
Anonymous
on 11-27-2008
Amgen Alters Anemia Drug Discounts
The company is halting some pricing practices that critics say were contributing to overuse of its flagship anemia drug Aranesp at a time of mounting concerns about the product’s safety.
Posted to
nytimes.com
(Weblog)
by
nytimes.com
on 08-28-2008
Amgen Alters Anemia Drug Discounts
The company is halting some pricing practices that critics say were contributing to overuse of its flagship anemia drug Aranesp at a time of mounting concerns about the product’s safety.
Posted to
partners.userland.com
(Weblog)
by
partners.userland.com
on 08-28-2008
Amgen to Stop Offering Discounts on Anemia Drug
The company is halting some pricing practices that critics say were contributing to overuse of its flagship anemia drug Aranesp at a time of mounting concerns about the product’s safety.
Posted to
nytimes.com
(Weblog)
by
nytimes.com
on 08-27-2008
Amgen to Stop Offering Discounts on Anemia Drug
The company is halting some pricing practices that critics say were contributing to overuse of its flagship anemia drug Aranesp at a time of mounting concerns about the product’s safety.
Posted to
partners.userland.com
(Weblog)
by
partners.userland.com
on 08-27-2008
Deal Seeks to Offer Drug for Malaria at Low Price
The Clinton Foundation announced an agreement among several drug makers that it hopes will assure a supply of a crucial malaria medicine at reasonable prices for the world’s poor.
Posted to
nytimes.com
(Weblog)
by
nytimes.com
on 07-17-2008
Deal Seeks to Provide Low-Priced Malaria Drugs
The Clinton Foundation announced an agreement among several drug makers that it hopes will assure a supply of a crucial malaria medicine at reasonable prices for the world’s poor.
Posted to
nytimes.com
(Weblog)
by
nytimes.com
on 07-17-2008
Deal Seeks to Provide Malaria Medicine at Low Prices
The Clinton Foundation announced an agreement among several drug makers that it hopes will assure a supply of a crucial malaria medicine at reasonable prices for the world’s poor.
Posted to
partners.userland.com
(Weblog)
by
partners.userland.com
on 07-17-2008
Page 1 of 1 (9 items)
This work is licensed under a
Creative Commons Attribution 3.0 United States License
.
* WebCrawler descriptions and academia provided in part by:
wikipedia.org
* All rights reserved to the original authors.
arachnode.net - a .NET web crawler written in C# using SQL 2005